Effect of type 2 diabetes mellitus on exercise intolerance and the physiological responses to exercise in peripheral arterial disease

Diabetologia

Volumn 50, Issue 4, 2007, Pages 859-866

  Green, S ^a,d   Askew, C D ^b   Walker, P J ^c  

^a UNIVERSITY OF NEW ENGLAND   (Australia)

^b UNIVERSITY OF THE SUNSHINE COAST   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

BMI; Claudication; Cycling; Diabetes; Intolerance; Oxygen uptake; Peripheral arterial disease; Walking

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ARTERY DISEASE; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CYCLING; EXERCISE PHYSIOLOGY; EXERCISE TOLERANCE; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; TREADMILL EXERCISE;

AGED; BODY MASS INDEX; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; EXERCISE; EXERCISE TOLERANCE; FEMALE; GLUCOSE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OXYGEN; PERIPHERAL VASCULAR DISEASES; WALKING;

EID: 33847649901     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0587-7     Document Type: Article

References (27)

1. Askew CD, Green S, Walker PJ et al (2005) Skeletal muscle phenotype is associated with exercise intolerance in patients with peripheral arterial disease. J Vasc Surg 41:802-807
2. 2 kinetics and resting skeletal muscle pyruvate dehydrogenase complex activity in peripheral arterial disease. Clin Sci 106:241-249
3. Hou X-Y, Green S, Askew C, Barker G, Green A, Walker PW (2002) Skeletal muscle mitochondrial ATP production rate and walking performance in peripheral arterial disease. Clin Physiol Funct Imaging 22:81-91
4. Regensteiner JG, Wolfel EE, Brass EP et al (1993) Chronic changes in skeletal muscle histology and function in peripheral arterial disease. Circulation 87:413-421
5. Askew C, Green S, Walker PM (2002) Physiological and symptomatic responses to walking and cycling in peripheral arterial disease. Clin Physiol Funct Imaging 22:348-355
6. Sorlie D, Myhre K (1978) Lower leg blood flow in intermittent claudication. Scand J Clin Lab Invest Suppl 38:171-179
7. Green S, Askew C (2001) The physiology of walking performance in peripheral arterial disease. In: Maffuli N, Chan KM, MacDonald R, Malina RM and Parker AW (eds) Sports medicine for specific ages and abilities. Churchill-Livingstone, Edinburgh, pp 385-393
8. Hiatt WR (2001) Medical treatment of peripheral arterial disease and claudication. N Engl J Med 344:1608-1621
9. Diehm C, Schuster A, Allenberg JR et al (2004) High prevalence of peripheral arterial disease and comorbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 172:95-105
10. Hiatt WR, Hoag S, Hamman RF (1995) Effect of diagnostic criteria on the prevalence of peripheral arterial disease: the San Luis Valley Diabetes Study. Circulation 91:1472-1479
11. Murabito JM, D'Agostino RB, Silbershatz H, Wilson WF (1997) Intermittent claudication: a risk profile from the Framingham Heart Study. Circulation 96:44-49
12. Hughson WG, Mann JI, Garrod A (1978) Intermittent claudication: prevalence and risk factors. Br Med J 1:1379-1381
13. Reunanen A, Takkunen H, Aromaa A (1982) Prevalence of intermittent claudication and its effect on mortality. Acta Med Scand 211:249-256
14. Stoffers HEJH, Kester AM, Kaiser V, Rinkens PELM, Knottnerus JA (1997) Diagnostic value of signs and symptoms associated with peripheral arterial occlusive disease seen in general practice: a multivariable approach. Med Decis Mak 17:61-70
15. Regensteiner JG, Sippel JM, McFarling ET, Wolfel EE, Hiatt WR (1995) Effects of non-insulin dependent diabetes on maximal exercise performance. Med Sci Sports Exerc 27:875-881
16. Regensteiner JG, Bauer TA, Reusch JEB et al (1998) Abnormal oxygen uptake kinetic responses in women with type II diabetes mellitus. J Appl Physiol 85:310-317
17. Wei M, Gibbons LW, Mitchell TL, Kampert JB, Lee CD, Blair SN (1999) The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men. Ann Intern Med 130:89-96
18. Oka RK, Sanders MG (2005) The impact of type 2 diabetes and peripheral arterial disease on quality of life. J Vasc Nurs 23:61-66
19. Katzel LI, Sorkin JD, Powell CC, Gardner AW (2001) Comorbities and exercise capacity in older patients with intermittent claudication. Vasc Med 6:157-162
20. Dolan NC, Liu K, Criqui MH et al (2002) Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care 25:113-120
21. Sanderson B, Askew C, Stewart I, Gibbs H, Walker PJ, Green S (2006) Short-term effects of cycle and treadmill training on exercise tolerance in peripheral arterial disease. J Vasc Surg 44:119-127
22. Labs KH, Dormandy JA, Jaeger KA, Stuerzebecher CS, Hiatt WR (1999) Transatlantic conference on clinical trial guidelines in peripheral arterial disease: clinical trial methodology. Circulation 100:e75-e81
23. Barker G, Green S, Walker PM (2004) Effect of carbohydrate supplementation on walking performance in peripheral arterial disease: a preliminary physiologic study. J Vasc Surg 40:932-938
24. Bauer TA, Regensteiner JG, Brass EP, Hiatt WR (1999) Oxygen uptake kinetics during exercise are slowed in patients with peripheral arterial disease. J Appl Physiol 87:809-816
25. m from the calf and thigh. Br J Surg 65:204-209
26. Green S (2002) Haemodynamic limitations and exercise performance in peripheral arterial disease. Clin Physiol Funct Imaging 22:81-91
27. van der Feen C, Neijens FS, Kanters SD, Mali WP, Stolk RP, Banga JD (2002) Angiographic distribution of lower extremity atherosclerosis in patients with and without diabetes. Diabet Med 19:366-370